November 05, 2024

Mediterranean Diets May Lower Brain Age, Study Finds

A recent trial suggests potential cognitive health benefits and reductions in brain age from following a green-Mediterranean diet rich in polyphenols, particularly for individuals with diabetes.

Conexiant

November 04, 2024

New Score Assesses Epilepsy Risk Post-CVT

With DIAS3 predicting epilepsy risk post-CVT from as low as 7% to 83% over three years, doctors can tailor ASM strategies based on a patient’s individual profile—advancing precision in CVT care.

Conexiant

November 01, 2024

Quitting Smoking: How Long Until CVD Risk Drops

Heavy ex-smokers face elevated CVD risk up to 25 years post-cessation, highlighting cumulative smoking burden's impact on cardiovascular health.

Conexiant

October 31, 2024

New TBI Guidelines Add Biomarker Screening

New ACS guidelines establish rapid VTE prophylaxis timelines and introduce validated blood-based biomarkers GFAP and UCH-L1 that could eliminate unnecessary CT scans in mild TBI cases.

Conexiant

October 31, 2024

Constipation Raises Cardiac Risk in Hypertensives

Researchers found that hypertensive patients with constipation faced higher odds of major adverse cardiac events compared to those with normal bowel habits, even after controlling for traditional cardiovascular risk factors and medications.

Conexiant

October 25, 2024

TESLA Trial: Does Thrombectomy Improve Outcomes in Large Strokes?

A recent trial assessed the efficacy of endovascular thrombectomy in patients with large infarcts detected by noncontrast CT, finding that it did not significantly improve 90-day functional outcomes.

Conexiant

October 25, 2024

TESLA Trial: Does Thrombectomy Improve Outcomes in Large Strokes?

Conexiant

October 24, 2024

Weight-Loss Drugs Linked to Higher Health Costs in 2 Years

Analysis of U.S. health insurance claims shows a 46% increase in average annual medical costs for patients with obesity two years after starting Wegovy or similar GLP-1 drugs, raising questions about the actual impact on medical outcomes and the potential demand for these highly effective yet expensive medicines.

Reuters

October 23, 2024

Cardiovascular Risk Linked to Migraine Status

Study reveals surprising findings on the relationship between cardiovascular risk and migraine prevalence in Dutch adults.

Conexiant